News

June 22, 2017June 22, 2017

$10M NIH Grant Aims to Identify Genes Linked to COPD, Other Diseases

News

The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health has granted $10 million to the McDonnell Genome Institute at Washington University to investigate and identify ... Read more

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis ... Read more

June 15, 2017June 15, 2017

Pulmatrix Licenses RespiVert’s Kinase Inhibitor Therapies for COPD and Other Lung Diseases

News

The lung therapy developer Pulmatrix has obtained global rights to RespiVert’s respiratory-disease treatments under a licensing arrangement. Under the deal, Pulmatrix gained access to the kinase inhibitors that RespiVert has developed for lung ... Read more

June 13, 2017June 13, 2017

BCBSTX to Invest $10 Million in COPD and Chronic Diabetic Kidney Disease Prevention in Texas

News

Blue Cross and Blue Shield of Texas (BCBSTX) is investing $10 million to raise awareness for the prevention and early detection of two diseases greatly affecting the health of Texans ... Read more

June 8, 2017June 8, 2017

Verona Pharma Announces New Clinical Trial for Inhaled Lung Therapy RPL554

News

Verona Pharma, a biopharmaceutical company developing therapeutics for the treatment of respiratory diseases, recently announced the initiation of a clinical trial in the United States for its product RPL554. The drug ... Read more

June 6, 2017June 6, 2017

Sunovion Receives FDA Letter Advancing Regulatory Status of SUN-101/eFlow Therapy to Treat COPD

News

Sunovion Pharmaceuticals has received a complete response letter from the U.S. Food and Drug Administration (FDA), clearing the Massachusetts company from having to conduct further clinical trials for approval of ... Read more

June 1, 2017June 1, 2017

Philips Acquires Airway Clearance Device Maker RespirTech and Expands COPD Therapeutic Portfolio

News

Dutch healthcare conglomerate Royal Philips has purchased RespirTech, a leading manufacturer of airway clearance therapy vests for patients with chronic obstructive pulmonary disease (COPD) and other severe lung conditions. With this new ... Read more

May 25, 2017May 25, 2017

Philips-sponsored Study Supports Use of Home Noninvasive Ventilation for COPD Treatment

News

A recent study, co-sponsored by Royal Philips, showed that using home noninvasive ventilation in addition to home oxygen therapy (HOT) could effectively delay hospital readmissions and increase survival in patients ... Read more

May 23, 2017May 23, 2017

Using Ventilator to Control Oxygen May Be COPD Game-changer, Study Suggests

News

Using a ventilator to control the level of supplemental oxygen a chronic obstructive pulmonary disease (COPD) patient receives halved patients’ trips to the hospital from disease flare-ups, according to ... Read more

May 18, 2017May 18, 2017

Company to Showcase Latest Lung Function Tests at ATS 2017 Conference

News

Ndd Medical Technologies will showcase the latest versions of its best-in-class spirometer and portable, all-in-one DLCO (diffusing capacity for carbon monoxide) devices for lung conditions such as chronic obstructive pulmonary ... Read more